Wen-Xu Jin
Overview
Explore the profile of Wen-Xu Jin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin Y, Zhou X, Chen Y, Jin W, Wang Y, Ye D, et al.
J Cancer
. 2019 Jul;
10(15):3543-3552.
PMID: 31293659
: Aldo-keto reductase family 1, member C2 (AKR1C2) gene encodes for a member of the AKR superfamily and participates in the metabolism of various drugs. Moreover, tumor and normal tissues...
2.
Jin W, Ye D, Sun Y, Zhou X, Wang O, Zhang X, et al.
Cancer Manag Res
. 2018 Sep;
10:3237-3243.
PMID: 30233240
Background: Preoperative diagnosis of central lymph node metastasis (CLNM) poses to be a challenge in clinical node-negative papillary thyroid microcarcinoma (PTMC). This research work aims at investigating the association existing...
3.
Li Q, Jin W, Jin Y, Zheng Z, Zhou X, Wang Q, et al.
Cancer Manag Res
. 2018 Jun;
10:1351-1358.
PMID: 29881305
Aim: To investigate the clinical effects of on papillary thyroid cancer (PTC) and explore the relationship between expression and mutation. Methods: The data of 69 patients subjected to fine-needle aspiration...
4.
Jin W, Jin Y, Ye D, Zheng Z, Sun Y, Zhou X, et al.
Med Sci Monit
. 2018 May;
24:2744-2749.
PMID: 29722351
BACKGROUND Skip metastasis is defined as metastasis incident to the lateral compartment without involvement of the central compartment, and is generally unpredictable in papillary thyroid cancer (PTC). The present study...
5.
Li Q, Zheng Z, Ni C, Jin W, Jin Y, Chen Y, et al.
Ann Clin Lab Sci
. 2018 Mar;
48(1):40-44.
PMID: 29530995
Background: Among all kinds of breast cancer, triple-negative breast cancer (TNBC) is the most aggressive, with the poorest prognosis and highest mortality rates. Thus, novel biomarkers that personalize the therapeutic...
6.
Wang Q, Cai Y, Chen Y, Zhang W, Jin W, Chen E, et al.
Ann Clin Lab Sci
. 2017 Mar;
47(1):68-75.
PMID: 28249920
Objective: This study aimed to investigate the prognostic value of lymph node ratio (LNR), number of removed lymph nodes (RLNs), and number of negative lymph nodes (NLNs) in Chinese patients...
7.
Wang Q, Chen E, Cai Y, Li Q, Jin Y, Jin W, et al.
J Exp Clin Cancer Res
. 2017 Jan;
36(1):18.
PMID: 28118854
No abstract available.
8.
Wang Q, Chen E, Cai Y, Zhou Y, Zheng Z, Wang Y, et al.
Onco Targets Ther
. 2016 Dec;
9:7161-7167.
PMID: 27920554
Purpose: Thyroid cancer is the most frequent malignancies of the endocrine system, and it has became the fastest growing type of cancer worldwide. Much still remains unknown about the molecular...
9.
Wang Q, Chen E, Cai Y, Li Q, Jin Y, Jin W, et al.
J Exp Clin Cancer Res
. 2016 Oct;
35(1):169.
PMID: 27793213
Background: Clinicians are confronted with an increasing number of patients with thyroid nodules. Reliable preoperative diagnosis of thyroid nodules remains a challenge because of inconclusive cytological examination of fine-needle aspiration...